[Excretion of cyclic adenosine monophosphate in breast and lung cancer].

Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver. J Clin Pathol (1979) 0.79

Breast self-examination for the early detection of breast cancer: a USSR/WHO controlled trial in Leningrad. Bull World Health Organ (1987) 1.29

Clinical trials on adjuvant chemotherapy for breast cancer. Cancer (1986) 0.92

[Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination]. Vopr Onkol (1996) 0.89

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol (2014) 0.89

Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84

[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. Mol Biol (Mosk) (2004) 0.84

Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume. Int J Androl (2002) 0.83

[The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity]. Tsitologiia (2006) 0.82

[Some aspects of the regeneration process carried out by means of pluripotent stem cells]. Tsitologiia (2008) 0.81

Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients. J Cancer Res Clin Oncol (1996) 0.81

Hereditary breast-ovarian cancer syndrome in Russia. Acta Naturae (2010) 0.80

[Changes in the expression of receptors of steroid hormones in the development of partial androgen deficiency of aging men (PADAM)]. Tsitologiia (2005) 0.80

[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79

Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78

[Comprehensive radiographic diagnosis of breast cancer]. Vopr Onkol (1996) 0.78

Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78

[Immunologic reactivity of breast cancer patients]. Vopr Onkol (1978) 0.78

[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78

[Age-related changes in adenylate cyclase activity, lipid composition and lipid peroxidation in rat intestinal mucosa: comparison with the frequency of spontaneous tumors]. Vopr Onkol (1985) 0.78

Geographical distribution of breast cancer in the USSR. Int J Cancer (1984) 0.77

[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77

[Combined use of 99mTc-MIBI scintigraphy and ultrasonography (US) in the diagnosis of axillary lymphatic metastasis in patients with breast cancer]. Vopr Onkol (2013) 0.77

[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77

[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77

[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77

Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76

[The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer]. Vopr Onkol (1967) 0.76

[Aromatase gene expression and its modifying factors in breast tumor tissue]. Vopr Onkol (1999) 0.76

[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer]. Vopr Onkol (2011) 0.76

[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76

[The role of breast cancer stem cells in metastasis]. Vopr Onkol (2015) 0.76

[Registry-based analysis of cancer and diabetes combination: prevalence and features]. Vopr Onkol (2007) 0.76

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76

[Endometrial cancer, estrogens and metabolic syndrome: scenario becomes more complicated]. Vopr Onkol (2014) 0.76

[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76

[Exosomal intercellular communication system and its role in the process of metastatic dissemination]. Vopr Onkol (2014) 0.76

[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol (2012) 0.75

[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75

[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75

[Content of cyclic nucleotides, cholesterol and phospholipids in tumors of the large intestine]. Vopr Onkol (1985) 0.75

[Amplification of the heterologous response of adenylate cyclase in colonic tumors: relation to tissue lipid composition]. Vopr Med Khim (1988) 0.75

[Adrenal steroids in patients with breast cancer and in women with age-related impaired glucose tolerance]. Vopr Onkol (1996) 0.75

[Effect of phenformin on fat-carbohydrate metabolism in pregnant rats]. Biull Eksp Biol Med (1976) 0.75

[Adaptational and thyroid homeostasis and the state of fat and carbohydrate metabolism in lung cancer]. Vopr Onkol (1978) 0.75

[Examination of pregnanediol in the urine by the method of thin layer chromatography on silica gel]. Lab Delo (1967) 0.75

[Diurnal urine sodium and potassium concentration in lung cancer patients]. Vopr Onkol (1970) 0.75

[Cyclic adenosine monophosphate and prostaglandins in oncology]. Vopr Onkol (1974) 0.75

[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75

[Estrogen-dependent peroxidase and hormone-dependent carcinogenesis]. Vopr Onkol (1999) 0.75

[Lipoprotein lipase: properties, change in activity with age and in some noninfectious human diseases]. Vopr Med Khim (1997) 0.75

[Effect of glucose on fetal weight and the transplacental blastomogenic effect of N-nitrosomethylurea in rats]. Eksp Onkol (1985) 0.75

[Adenylate cyclase complex, lipids and the regulation of the hormonal sensitivity of tumor tissue]. Eksp Onkol (1986) 0.75

[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75

[Carcinoembryonic antigen in the blood in the process of correcting carbohydrate metabolic disorders in patients with gastrointestinal cancer]. Med Radiol (Mosk) (1983) 0.75

[Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients]. Vopr Onkol (1980) 0.75

[Size and number of adipocytes in the perirenal fatty tissue in pregnancy and in the postpartum period in rats]. Biull Eksp Biol Med (1977) 0.75

[Inhibition of the hypercalcemic effect of endogenous parathyroid hormone by its azo derivative in the EDTA test]. Vopr Med Khim (1972) 0.75

[Thyroxine depression of compensatory hypertrophy of the thyroid gland in rats of different ages]. Biull Eksp Biol Med (1975) 0.75

[Ectopic endocrine syndromes]. Vopr Onkol (1968) 0.75

[75th anniversary of the publication of N. N. Petrov's manual "A General Theory of Tumors"]. Vopr Onkol (1985) 0.75

[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75

[Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer]. Vopr Onkol (1996) 0.75

[Antibodies to thyroglobulin in patients with cancer]. Vopr Onkol (1977) 0.75

[On the unification of the expression of results of determination of steroid hormones in urine]. Lab Delo (1969) 0.75

[Molecular-genetic aspects of estrogen production. Aromatase gene]. Mol Biol (Mosk) (1998) 0.75

[Inhibition of growth, fat-mobilization and lactogenic effects of somatotropic hormone with antiserum to anahormone of human placental lactogen]. Biull Eksp Biol Med (1972) 0.75

[Evolutionary oncoendocrinology]. Zh Evol Biokhim Fiziol (2001) 0.75

[Dexamethasone and dibutyryl-cyclic AMP stimulates conversion of androstenedione in human blood lymphocytes]. Dokl Akad Nauk (1997) 0.75

[Insulin-like growth factor-1, its binding protein (BP-3) and insulin in colorectal cancer]. Vopr Onkol (2001) 0.75

[Prostaglandins and their physiologic role]. Usp Fiziol Nauk (1976) 0.75

[Prognosis of breast cancer patients with large-fetus birth weights in their history]. Vopr Onkol (1981) 0.75

[Aromatase activity in human muscle tissue]. Vopr Med Khim (1997) 0.75

[Effect of phenformin (dibotin) on the state of fat-carbohydrate metabolism and fetal weight in pregnant rats previously given alloxan]. Patol Fiziol Eksp Ter (1977) 0.75

[A model of hypoparathyroidism induced by antibodies to active parathormone and its anahormone]. Patol Fiziol Eksp Ter (1972) 0.75

[Effect of hypolipidemic preparations on basal and stimulated adenylate cyclase activity in tumor cells]. Biull Eksp Biol Med (1985) 0.75

[Retrospective data on the weight of newborn infants in oncological patients]. Vopr Onkol (1973) 0.75

[Anahormone-chimeras. Hormonally-inactive conjugate of bovine ACTH and human somatotropin, retaining the antigenic properties of the original hormones]. Dokl Akad Nauk SSSR (1972) 0.75

[Effect of thyroxine on radioactive iodine accumulation in the thyroid glands of hemithyroidectomized rats of different ages]. Biull Eksp Biol Med (1978) 0.75

[Effect of phenformin on fetal mass in rats previously immunized with an extract of homologous thyroid gland]. Biull Eksp Biol Med (1981) 0.75

[Cyclic nucleotides in clinical oncology]. Vopr Onkol (1982) 0.75

[Effect of neoadjuvant therapy with neovir on the level of steroid hormone receptors in endometrial cancer tissue]. Vopr Onkol (2001) 0.75

[Molecular biological and biochemical features of breast cancer]. Vestn Ross Akad Med Nauk (1998) 0.75

[Peroxidase activity in human uterine tissue: connection with clinico-morphological features of endometrial cancer]. Vopr Onkol (2001) 0.75

[Morphometric and biochemical peculiarities of fatty tissue in patients with cancer of the breast and lung]. Vopr Onkol (1983) 0.75

[Use of suppositories for rectal immunization]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75

[Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up]. Vopr Onkol (1987) 0.75

[Effect of systemic and central triiodothyronine administration on compensatory hypertrophy of the thyroid gland in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1980) 0.75

[Current trends in the biological therapy of malignant tumors]. Vopr Onkol (1996) 0.75

[Comparative study of subcutaneous, rectal and peroral immunization with hormonal and nonhormonal proteins]. Patol Fiziol Eksp Ter (1978) 0.75

[Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking]. Vopr Onkol (2000) 0.75

[Characteristics of the hormonal metabolic status of patients with colonic and rectal cancer]. Eksp Onkol (1988) 0.75

[Endocrine changes in cancer of the rectum and colon]. Vopr Onkol (1987) 0.75

[Cyclic adenosine monophosphate in the fatty tissue of breast and lung cancer patients]. Vopr Med Khim (1982) 0.75

[Cyclic adenosine monophosphate content in the lymphocytes of cancer patients]. Eksp Onkol (1985) 0.75

[Effect of human serum lipoproteins on various indices of thyroid function in rats]. Probl Endokrinol (Mosk) (1982) 0.75

[Effect of thyroxine, insulin and cholesterol on the amount of cyclic adenosine monophosphate in normal and oncornavirus infected cells]. Tsitologiia (1977) 0.75

[Some functional characteristics of the genital system preceding the development of breast tumors]. Akush Ginekol (Mosk) (1973) 0.75

[Conversion of androstenedione in the lymphocytes infiltrating the breast tumor tissue]. Biull Eksp Biol Med (1997) 0.75

[Penetration of 3H-cyclic adenosine-3',5'-monophosphate into different tissues of mice]. Biull Eksp Biol Med (1982) 0.75

[Catecholestrogens: synthesis, properties and role in carcinogenesis]. Vopr Onkol (1997) 0.75